Cardiac Solutions
Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world
Platform · HybridCompany source
Company profile
About Clario
Clario is a clinical trial technology company that provides comprehensive endpoint solutions and evidence generation services for pharmaceutical, biotechnology, and contract research organizations. Now part of Thermo Fisher Scientific, Clario specializes in evaluating drug efficacy, safety, and patient quality of life through digital endpoint technologies. The company's portfolio spans cardiac solutions (ECG, arrhythmia analysis, blood pressure monitoring), electronic Clinical Outcome Assessments (eCOA), medical imaging core lab services, precision motion measurement using wearable sensors, and respiratory solutions including spirometry. Clario serves clients across all trial phases from Phase I through Phase IV, supporting both site-based and hybrid/decentralized clinical trials. The company has been pioneering AI-enabled solutions in clinical trials since 2018, with over 30 AI-powered tools deployed across 600+ active trials. Clario's technology platform includes advanced data collection, quality control, and analytics capabilities designed to accelerate drug development while reducing risk. The company serves multiple therapeutic areas including cardiovascular, neuroscience, oncology, respiratory, dermatology, gastroenterology, and ophthalmology. With a focus on regulatory compliance and scientific rigor, Clario employs key opinion leaders and clinical specialists to ensure high-quality, regulatory-ready data collection and analysis.
Company description Clario official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Clario?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiovascular diseases
- Dermatology
- Diabetes and obesity
- Gastroenterology
- Hepatology
- Infectious diseases
- Metabolic disorders
- Musculoskeletal disorders
- Neuroscience conditions (dementias, headache disorders, movement disorders, multiple sclerosis, pain disorders, psychiatric disorders)
- Oncology
- Ophthalmology
- Respiratory diseases
Who it serves
- Biotechnology companies
- Contract Research Organizations (CROs)
- Healthcare providers
- Pharmaceutical companies
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
Acquired by Thermo Fisher Scientific (timing not specified in scraped content), deployed over 30 AI-enabled solutions across 600+ active trials since 2018
Partnerships
Recorded partners
- Thermo Fisher Scientific (acquired by)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
eCOA (Electronic Clinical Outcome Assessment)
Make trials easier to run, faster to launch, more engaging, and accessible to all
Platform · Cloud SaaSCompany source
Image Redact AI
Automatically redacts sensitive patient identifiers from videos, photos and PDFs
Software · Cloud SaaSCompany source
Medical Imaging
Accelerate drug development and reduce risk with comprehensive medical imaging core lab services
Platform · Cloud SaaSCompany source
Precision Motion
Complete solution for measuring objective digital endpoints of mobility with wearable sensor technology
Device · HybridCompany source
Respiratory Solutions
Generate reliable pulmonary data with low variability and high patient compliance
Platform · HybridCompany source
SMART Submit
Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards
Platform · Cloud SaaSCompany source
Trial Enablement
Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Analysis of Interindividual Lesion Progression Variability in Adult Cerebral Adrenoleukodystrophy.Neurology · Sep 8, 2026
Total body and appendicular lean mass by dual-energy X-ray absorptiometry are highly associated with muscle function and bone mineral density in Becker muscular dystrophy.Journal of neuromuscular diseases · Aug 28, 2026
Corrigendum to "exploratory anchor-based analyses to determine minimal clinically important differences for the brief assessment of cognition in schizophrenia and the schizophrenia cognition rating scale" [Schizophr. Res. 2026 July 25. doi:10.1016/j.schres.2026.07.021. Epub ahead of print].Schizophrenia research · Aug 18, 2026
Exploratory anchor-based analyses to determine minimal clinically important differences for the Brief Assessment of Cognition in Schizophrenia and the Schizophrenia Cognition Rating Scale.Schizophrenia research · Jul 25, 2026
A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical Trials.Biological psychiatry · Jul 15, 2026
Feasibility and safety of the Mobility Rehab Auditory Feedback system for gait in people with Parkinson's disease: A pilot study.Gait & posture · Jul 1, 2026
Clinical validation
Clinical-trial records
Randomized Study in Children and Adolescents With Migraine: Acute TreatmentNCT04649242 · Mentioned · RECRUITING
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineNCT04743141 · Mentioned · RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyNCT05556343 · Mentioned · TERMINATED
12-Week Strength and Functional Exercise Program for Hereditary Spastic Paraplegia Trial (HSPMOVE)NCT07561359 · Mentioned · ENROLLING BY INVITATION
Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's DiseaseNCT07518290 · Mentioned · RECRUITING
Pain Intervention With Needling: Pilot Of Integrated Neuromodulation TechniquesNCT07112404 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Trial setup acceleration
Deploy early phase oncology trials in as little as 2 weeks with eCOA Swift
Data quality enhancement
Over 30 AI-enabled solutions enhancing data quality across 600+ active trials
Low variability pulmonary data
Generate reliable pulmonary data with low variability and high patient compliance
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Clario
Recent articles published on Clario's official website.
Biological Psychiatry Study Shows Speech-Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials
Read on ClarioClario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman
Read on ClarioThermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Read on ClarioClario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System
Read on ClarioClario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control
Read on Clario07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.